Publications Print Laughlin BS, Bhangoo RS, Niska JR, Thorpe CS, Girardo ME, Anderson JD, Kosiorek HE, McGee LA, Hartsell WF, Chang JH, Rossi CJ, Tsai HK, Choi IJ, Vargas CE. Proton therapy for isolated local regional recurrence of breast cancer after mastectomy alone. Front Oncol. 2022; 12:925078. Epub 2022 Nov 28. View PubMed Niska JR, Hu J, Li J, Herman MG, Thorpe CS, Schild SE, Fatyga M. Using Novel Statistical Techniques to Accurately Determine the Predictive Dose Range in a Study of Overall Survival after Definitive Radiotherapy for Stage III Non-Small Cell Lung Cancer in Association with Heart Dose. J Cancer Ther. 2021 Sep; 12 (9):505-529 Epub 2021 Sept 29 View PubMed Yu NY, Niska JR. Azygous tumor thrombus extending into the heart. J Cardiovasc Comput Tomogr 2020 Sep - Oct; 14 (5):e9-e10 Epub 2018 Oct 06 View PubMed Thorpe CS, Niska JR, Anderson JD, Girardo ME, McGee LA, Hartsell WF, Larson GL, Tsai HK, Rossi CJ, Rosen LR, Vargas CE. Acute toxicities after proton beam therapy following breast-conserving surgery for breast cancer: Multi-institutional prospective PCG registry analysis. Breast J. 2020 Sep; 26 (9):1760-1764 Epub 2020 Apr 15 View PubMed Niska JR, Thorpe CS, Halyard MY, Tan AD, Atherton PJ, Dueck AC, Patel SH, Sloan JA. Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy. J Patient Rep Outcomes. 2020 Jul 16; 4 (1):60 Epub 2020 July 16 View PubMed Thorpe CS, Niska JR, Girardo ME, Kosiorek HE, McGee LA, Hartsell WF, Larson GL, Tsai HK, Rossi CJ, Rosen LR, Vargas CE. Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis. Breast J. 2019 Nov; 25 (6):1160-1170 Epub 2019 July 23 View PubMed Vargas CE, Alam NB, Terk M, Niska JR, Cesaretti J, Swartz D, Vashi A, Kasraeian A, West CS, Blasser M, Moore C. Initial results of a randomized phase III trial of high dose image guided radiation with or without androgen deprivation therapy for intermediate-risk prostate cancer. Cancer Treat Res Commun. 2019; 19:100119 Epub 2019 Feb 10 View PubMed Niska JR, Thorpe CS, Allen SM, Daniels TB, Rule WG, Schild SE, Vargas CE, Mookadam F. Radiation and the heart: systematic review of dosimetry and cardiac endpoints. Expert Rev Cardiovasc Ther. 2018 Dec; 16 (12):931-950 Epub 2018 Nov 01 View PubMed Vargas CE, Schmidt MQ, Niska JR, Hartsell WF, Keole SR, Doh L, Chang JH, Sinesi C, Rodriquez R, Pankuch M, Larson GL. Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer. Adv Radiat Oncol. 2018 Jul-Sep; 3 (3):322-330 Epub 2018 Feb 23 View PubMed Thorpe CS, Niska JR, Brunnhoelzl DC, McGee LA, Kesslering CM, Hartsell WF, Vargas CE. First report of proton beam therapy for breast angiosarcoma from the prospective PCG registry. Acta Oncol 2018 Jul; 57 (7):992-994 Epub 2018 Jan 05 View PubMed Niska JR, Schild SE, Rule WG, Daniels TB, Jett JR. Fatal Radiation Pneumonitis in Patients With Subclinical Interstitial Lung Disease. Clin Lung Cancer. 2018 Jul; 19 (4):e417-e420 Epub 2018 Feb 17 View PubMed Niska JR, Keole SR, Pockaj BA, Halyard MY, Patel SH, Northfelt DW, Gray RJ, Wasif N, Vargas CE, Wong WW. Choosing wisely after publication of level I evidence in breast cancer radiotherapy. Breast Cancer (Dove Med Press). 2018; 10:31-37 Epub 2018 Feb 09 View PubMed Niska JR, Halyard MY, Tan AD, Atherton PJ, Patel SH, Sloan JA. Electronic patient-reported outcomes and toxicities during radiotherapy for head-and-neck cancer. Qual Life Res. 2017 Jul; 26 (7):1721-1731 Epub 2017 Feb 28 View PubMed Howarth AL, Niska JR, Brooks K, Anand A, Bues M, Vargas CE, Mahabir RC. Tissue Expanders and Proton Beam Radiotherapy: What You Need to Know. Plast Reconstr Surg Glob Open. 2017 Jun; 5 (6):e1390 Epub 2017 June 23 View PubMed Niska JR, Keane FK, Wolfgang JA, Hahn PF, Wo JY, Zhu AX, Hong TS. Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trial. Pract Radiat Oncol. 2016 Jan-Feb; 6: (1)e9-16. View PubMed Balboni MJ, Sullivan A, Enzinger AC, Epstein-Peterson ZD, Tseng YD, Mitchell C, Niska J, Zollfrank A, VanderWeele TJ, Balboni TA. Nurse and physician barriers to spiritual care provision at the end of life. J Pain Symptom Manage. 2014 Sep; 48: (3)400-10. View PubMed Niska JR, Cohen JM, Fagin AP, Hariton E, Pierce MW, Kuriyama A, Whelan JS, Jackson JL, Dimitrakoff JD. Therapeutic intervention for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a systematic review and meta-analysis. PLoS One. 2012; 7: (8)e41941. View PubMed Willis AL, Tran NL, Chatigny JM, Charlton N, Vu H, Brown SA, Black MA, McDonough WS, Fortin SP, Niska JR, Winkles JA, Cunliffe HE. The fibroblast growth factor-inducible 14 receptor is highly expressed in HER2-positive breast tumors and regulates breast cancer cell invasive capacity. Mol Cancer Res. 2008 May; 6: (5)725-34. View PubMed PST-20571536 Home Publications